skip to Main Content
Get Board Certified
BECOME CERTIFIED
Overview
Board Eligibility
Fees
FAQs
Candidate Handbook
ABOUT THE EXAM
BCMTMS™ Exam Overview
Examination Scheduling
Testing Dates
Exam Content Outline
Exam Prep Resources
Handbook
test
APPLY NOW
Maintain Certification
MAINTAIN CERTIFICATION
Renewal Cycle
Recertification Process
Recertification Handbook
MTM Certificate
Menu 3
About
ABOUT NBMTM
Mission, Vision & Values
History
Leadership & Governance
Accreditation
Volunteer Opportunities
ABOUT OUR CERTIFICATION
MTM Certification
BCMTMS
A Trusted Credential
Reports and Pass Rates
my
NBMTM
Search
Search
Submit
Menu
Feed Items
Home
|
Hyperthermic intraperitoneal chemotherapy in ovarian cancer
Hyperthermic intraperitoneal chemotherapy in ovarian cancer
January 19, 2018
Hyperthermic intraperitoneal chemotherapy in ovarian cancer
Published on 01/18/2018
Tweet
Share
Share
previous post:
Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis
next post:
A systematic review and meta-analysis of efficacy and safety of novel interleukin inhibitors in the management of psoriatic arthritis
Get Board Certified
Overview
Board Eligibility
BCMTMS™ Exam Overview
Testing Dates
Fees
Exam Content Outline
Exam Prep Resources
Candidate Handbook
Maintain Certification
Renew Certification
Renewal Cycle
Recertification Process
Recertification Handbook
About
Mission, Vision & Values
History
Leadership & Governance
Accreditation
MTM Certification
A Trusted Credential
Login
Back To Top
